Oligonucleotide-Based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets - United Arab Emirates
doi 10.2174/1389450003349344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Antisense Oligonucleotide Therapy for Neurodegenerative Disease

Journal of Clinical Investigation
Medicine
2006English

Antisense Oligonucleotide Gene Therapy for Neuromuscular Disorders

University of Ottawa Journal of Medicine
2018English

Oligonucleotide Aptamers: Therapeutics and Clinical Applications

Japanese Journal of Thrombosis and Hemostasis
2020English

Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease

Recent Patents on Cardiovascular Drug Discovery
2014English

Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism

Hypertension
Internal Medicine
2001English

miRNA-based Therapies: Strategies and Delivery Platforms for Oligonucleotide and Non-Oligonucleotide Agents

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2014English

124. AAV-Mediated Antisense Oligonucleotide-Based Therapy for CEP290-Associated LCA

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics

Pharmacological Reviews
Molecular MedicinePharmacology
2019English

Oligonucleotide-Based Assays for Integrase Activity

Methods
BiochemistryGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy